http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7936444

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 3760
issn 1535-7163
1538-8514
issueIdentifier 12
pageRange 3751-3760
publicationName Molecular Cancer Therapeutics
startingPage 3751
bibliographicCitation Yang Z, Yang S, Misner BJ, Chiu R, Liu F, Meyskens FL. Nitric oxide initiates progression of human melanoma via a feedback loop mediated by apurinic/apyrimidinic endonuclease-1/redox factor-1, which is inhibited by resveratrol. Mol Cancer Ther. 2008 Dec;7(12):3751–60. doi: 10.1158/1535-7163.mct-08-0562. PMID: 19074850.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_25bd5162aa7ea5971655fb14a06322fa
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c5bf1ec1aa8fa271b376d4c732fdd098
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a44f690e6ee75f24de57f7d553f59290
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bab49f3fc9f35facd67c20c0833e1f7e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_58a27e8153ea45e249c8e5a5b4592000
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2866cda3e854ed8fb30b9a5d753cf66e
date 2008-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1158/1535-7163.mct-08-0562
https://pubmed.ncbi.nlm.nih.gov/19074850
isPartOf https://portal.issn.org/resource/ISSN/1538-8514
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30097
https://portal.issn.org/resource/ISSN/1535-7163
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Nitric oxide initiates progression of human melanoma via a feedback loop mediated by apurinic/apyrimidinic endonuclease-1/redox factor-1, which is inhibited by resveratrol
discusses http://id.nlm.nih.gov/mesh/M0014877
http://id.nlm.nih.gov/mesh/M0001486
http://id.nlm.nih.gov/mesh/M0073416
http://id.nlm.nih.gov/mesh/M0165532
http://id.nlm.nih.gov/mesh/M0225993
http://id.nlm.nih.gov/mesh/M0028161
http://id.nlm.nih.gov/mesh/M0020537
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000972Q000494
http://id.nlm.nih.gov/mesh/D043603Q000502
http://id.nlm.nih.gov/mesh/D008545Q000473
http://id.nlm.nih.gov/mesh/D015971
http://id.nlm.nih.gov/mesh/D015972
http://id.nlm.nih.gov/mesh/D009569Q000378
http://id.nlm.nih.gov/mesh/D013267Q000494
hasSubjectTerm http://id.nlm.nih.gov/mesh/D008954
http://id.nlm.nih.gov/mesh/D043603Q000378
http://id.nlm.nih.gov/mesh/D018450
http://id.nlm.nih.gov/mesh/D018808Q000502
http://id.nlm.nih.gov/mesh/D000972Q000378
http://id.nlm.nih.gov/mesh/D008545Q000378
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D049109
http://id.nlm.nih.gov/mesh/D000077185
http://id.nlm.nih.gov/mesh/D045744
http://id.nlm.nih.gov/mesh/D025461
http://id.nlm.nih.gov/mesh/D009362
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d3620b6aab99399a07419eb4d661e6c0
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8448
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b74b10ce265f3fe9d63c2893394b8b3e
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.24.7
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID145068
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e035e53b5a717e4b6fb1217eb808b805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445154
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4f3366af2ce1555e259faab86aad3bef
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1e17cdb03f1040bcce1a0ed3b7f9fb5c

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128542940
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID328

Total number of triples: 64.